Acumen Pharmaceuticals, Inc. (ABOS)
Market Open
20 Jul, 17:03
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 19
-0.06
-2.8889%
$
153.25M Market Cap
- P/E Ratio
- Div Yield
23,508 Volume
- Eps
$ 2.25
Previous Close Want to track ABOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acumen Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 67,375 | $149,913.6 | $146,877.5 | -$3,036.1 | -2.03% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 45,600 | $77,541 | $102,600 | $25,059 | 32.32% |
| TK Taro Kuriyama Axq Capita LLP | 28,487 | $67,229 | $64,095.75 | -$3,133.25 | -4.66% |
 Daniel Ronan Catalyst Financial Partners LLC | 89,699 | $431,452 | $201,822.75 | -$229,629.25 | -53.22% |
| PIL PFG Investments LLC PFG Investments LLC | 80,850 | $181,456 | $181,912.5 | $456.5 | 0.25% |
 Christopher C. Powers Farther Finance Advisors, LLC | 200 | $232 | $450 | $218 | 93.97% |
| RJ Rebecca Judd Pathstone Holdings, LLC | 859,110 | $1.74M | $1.93M | $188,470.34 | 10.8% |
 Clune & Associates Ltd. Clune & Associates Ltd. | 16,500 | $28,380 | $37,125 | $8,745 | 30.81% |
